rifaximin, Xifaxan

Pharmacy Author:
Medical and Pharmacy Editor:

GENERIC NAME: rifaximin


DRUG CLASS AND MECHANISM: Rifaximin is a semi-synthetic antibiotic used for treating traveler's diarrhea and hepatic encephalopathy. It is derived from rifamycin, a naturally occurring chemical produced by a bacterium called Streptomyces mediterranei. Rifaximin is active against Escherichia coli bacterial strains that cause traveler's diarrhea, preventing growth of the bacteria by preventing them from manufacturing proteins needed for their replication and survival. By suppressing growth of the bacteria, rifaximin reduces symptoms of traveler's diarrhea. Hepatic encephalopathy is a serious neurologic complication of advanced liver disease that affects the brain. It is believed to be caused by the absorption of ammonia and other chemicals produced by bacteria in the intestine. It is believed that rifaximin prevents and treats hepatic encephalopathy by reducing the intestinal bacteria that produce ammonia. The FDA approved rifaximin in May 2004.

Medically Reviewed by a Doctor on 3/30/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index